New Publication: MADRAC Bulletin December 2015

Star InactiveStar InactiveStar InactiveStar InactiveStar Inactive
Bulletin MADRAC Dec 2015
Click the image to download/view MADRAC Bulletin – Dec 2015.


  • Succinylated Gelatin Intravenous Infusion Products - Summary of Safety Review in 2015
  • Amlodipine: Possible Risk of Blurred Vision
  • Cardiovascular Adverse Events Related to Diclofenac
  • Direct Healthcare Professional Communications (DHPCs) Reviewed and Approved by NPCB in 2015
  • Montelukast: Risk of Thrombocytopenia
  • Dipeptidyl Peptidase-4 (DPP-4) Inhibitors: Risk of Severe Joint Pain
  • Fusafungine: Risk of Serious Allergic Reactions
  • New and Improved ADR Reporting Form (Blue Form)
  • ADR Reports Involving Anti-Tuberculosis Drugs
Click here for other issues of MADRAC Bulletin.

Comments (0)

There are no comments posted here yet

Leave your comments

Posting comment as a guest.
0 Characters
Attachments (0 / 3)
Share Your Location

National Pharmaceutical Regulatory Agency (NPRA)
Lot 36, Jalan Universiti, 46200 Petaling Jaya, Selangor, Malaysia.
  • Email:
  • Phone: +603-7883 5400
  • Fax: +603-7956 2924, +603-7956 7075


The Government of Malaysia and the National Pharmaceutical Regulatory Agency are not responsible for any loss or damage caused by the usage of any information obtained from this website.

Mobile Web :

© Copyright 2019 . All Rights Reserved National Pharmaceutical Regulatory Agency NPRA

Main Menu English

Choose Your Language